Arsanis, Inc. Business Operations Contracts & Agreements
12 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Indemnification Agreements (4)
- Services Agreements (6)
- Settlement Agreements (1)
- Amendment No. 2 to Master Services Agreement, dated February (Filed With SEC on March 19, 2021)
- Amendment No. 1 to Master Services Agreement, dated February 19, 2016, by and between X4 Pharmaceuticals Inc. and Aptuit (Oxford) Limited (Filed With SEC on March 12, 2020)
- Master Services Agreement, dated February 19, 2016, by and between X4 Pharmaceuticals Inc. and Aptuit (Oxford) Limited (Filed With SEC on March 12, 2020)
- Amendment No. 2 to Master Services Agreement, dated February 28, 2020, by and between X4 Pharmaceuticals Inc. and Mayne Pharma Inc (Filed With SEC on March 12, 2020)
- Amendment No. 1 to Master Services Agreement, dated August 25, 2017, by and between X4 Pharmaceuticals Inc. and Mayne Pharma Inc. (formerly known as Metrics, Inc.) (Filed With SEC on March 12, 2020)
- Master Services Agreement, dated September 10, 2015, by and between X4 Pharmaceuticals Inc. and Mayne Pharma Inc. (formerly known as Metrics, Inc.) (Filed With SEC on March 12, 2020)
- Settlement Agreement, dated as of March 8, 2019, by and among X4 Pharmaceuticals, Inc. (formerly Arsanis, Inc.), Artemis AC Corp., X4 Therapeutics, Inc. (formerly X4... (Filed With SEC on April 11, 2019)
- INDEMNIFICATION AGREEMENT (Filed With SEC on November 6, 2017)
- Form of Indemnification Agreement to be entered into between the Registrant and each of its directors and executive officers (Filed With SEC on October 20, 2017)
- Collaboration Agreement, dated as of May 1, 2011, by and between the Registrant and Adimab, LLC, as amended (Filed With SEC on October 20, 2017)
- Form of Indemnification Agreement between Registrant and each of Eszter Nagy, Tillman U. Gerngross and Rene Russo (Filed With SEC on October 20, 2017)
- Form of Indemnification Agreement between Registrant and each of William Clark, Carl Gordon, David McGirr, Terrance McGuire, Claudio Nessi, Michael Ross and Amy Schulman (Filed With SEC on October 20, 2017)
